Alexandria Real Estate Equities, Inc. $ARE Stock Bought by Nan Fung Trinity HK Ltd.

Nan Fung Trinity HK Ltd. boosted its position in shares of Alexandria Real Estate Equities, Inc. (NYSE:ARE) by 13.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 238,981 shares of the real estate investment trust’s stock after acquiring an additional 28,181 shares during the period. Nan Fung Trinity HK Ltd. owned 0.14% of Alexandria Real Estate Equities worth $11,342,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of Alexandria Real Estate Equities during the second quarter worth $1,146,423,000. Dimensional Fund Advisors LP boosted its position in shares of Alexandria Real Estate Equities by 2.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,297,222 shares of the real estate investment trust’s stock worth $106,638,000 after purchasing an additional 52,733 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Alexandria Real Estate Equities in the 2nd quarter worth $79,253,000. Legal & General Group Plc purchased a new position in Alexandria Real Estate Equities during the 2nd quarter worth $76,647,000. Finally, Hsbc Holdings PLC purchased a new position in Alexandria Real Estate Equities during the 2nd quarter worth $64,485,000. 96.54% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ARE has been the topic of several recent analyst reports. BMO Capital Markets reduced their target price on Alexandria Real Estate Equities from $52.00 to $48.00 and set a “market perform” rating on the stock in a research report on Monday, September 28th. Raymond James Financial set a $41.00 price target on Alexandria Real Estate Equities in a report on Monday, October 12th. BNP Paribas Exane dropped their price target on Alexandria Real Estate Equities from $40.00 to $37.00 and set an “underperform” rating on the stock in a research note on Wednesday, October 28th. Evercore restated an “outperform” rating and set a $59.00 price objective on shares of Alexandria Real Estate Equities in a report on Monday, September 21st. Finally, Cantor Fitzgerald cut their price objective on shares of Alexandria Real Estate Equities from $52.00 to $42.00 and set a “neutral” rating on the stock in a report on Wednesday, October 28th. Two investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $49.79.

Insider Transactions at Alexandria Real Estate Equities

In other Alexandria Real Estate Equities news, Chairman Joel S. Marcus purchased 5,000 shares of the firm’s stock in a transaction dated Friday, September 11th. The shares were purchased at an average cost of $49.68 per share, with a total value of $248,400.00. Following the completion of the purchase, the chairman owned 597,724 shares in the company, valued at approximately $29,694,928.32. This represents a 0.84% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CAO Andres Gavinet sold 10,000 shares of the business’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $50.93, for a total transaction of $509,300.00. Following the transaction, the chief accounting officer owned 102,516 shares in the company, valued at $5,221,139.88. The trade was a 8.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.35% of the company’s stock.

Alexandria Real Estate Equities Price Performance

Shares of NYSE ARE opened at $44.25 on Friday. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.14 and a quick ratio of 0.14. The stock has a market capitalization of $7.71 billion, a price-to-earnings ratio of 6.30 and a beta of 1.17. The firm’s 50 day simple moving average is $46.66 and its 200-day simple moving average is $49.11. Alexandria Real Estate Equities, Inc. has a 12 month low of $38.34 and a 12 month high of $59.76.

Alexandria Real Estate Equities (NYSE:ARE) last posted its earnings results on Monday, October 26th. The real estate investment trust reported ($3.74) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($3.71). The firm had revenue of $671.18 million for the quarter, compared to analysts’ expectations of $646.26 million. Alexandria Real Estate Equities had a negative return on equity of 7.52% and a negative net margin of 51.81%. The company’s revenue was down 10.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.22 earnings per share. Analysts expect that Alexandria Real Estate Equities, Inc. will post 6.39 EPS for the current year.

Alexandria Real Estate Equities Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date was Wednesday, September 30th. Alexandria Real Estate Equities’s dividend payout ratio is -34.20%.

About Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc. is a real estate investment trust specializing in life science, technology and other knowledge-based industries. Founded in 1994, the company develops, owns and operates collaborative campuses that bring together companies, researchers and institutions. Its properties include laboratory, office and manufacturing space, as well as related facilities and amenities designed to support research and innovation. Alexandria also makes strategic investments in companies in the life science and technology sectors through its venture investment platform.